FibroGen Inc (NAS:FGEN)
$ 1.19 0.01 (0.85%) Market Cap: 118.38 Mil Enterprise Value: 89.74 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 58/100

FibroGen Inc Annual Shareholders Meeting Transcript

May 26, 2021 / 07:00PM GMT
Release Date Price: $20.86 (+0.92%)
Operator

Good afternoon, and welcome to the 2021 Annual Meeting of Stockholders of FibroGen, Inc. I would now like to turn the call over to Enrique Conterno, the CEO and Director of FibroGen. Please go ahead.

Enrique A. Conterno
FibroGen, Inc. - CEO & Director

Thank you, and good afternoon. I'm pleased to welcome everyone to the FibroGen 2021 Annual Meeting of Stockholders. At the request of the Chairperson of our Board, Jim Schoeneck, I will act as Chairman of this meeting. Since our online annual meeting is being conducted on a new platform this year, please bear with us if we encounter any technical issues.

Before I call the meeting to order, I would like to take a moment to recognize and thank Dr. Kalevi Kurkijärvi for serving on our Board of Directors for 24 years and who will be retiring at the end of June. Kalevi brought significant experience across a number of areas to the company and made significant contributions over the years. We thank him for his efforts and wish him well.

I would now like to introduce to you the members of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot